- Source: 14-Methoxymetopon
14-Methoxymetopon is an experimental opioid drug developed by a team led by Professor Helmut Schmidhammer at the University of Innsbruck in the mid-1990s. It is a derivative of metopon in which a methoxy group has been inserted at the 14-position. It is a highly potent analgesic drug that is around 500 times stronger than morphine when administered systemically; however, when given spinally or supraspinally, it exhibits analgesic activity up to a million fold greater than morphine. It binds strongly to the μ-opioid receptor and activates it to a greater extent than most similar opioid drugs. This produces an unusual pharmacological profile, and although 14-methoxymetopon acts as a potent μ-opioid full agonist in regard to some effects such as analgesia, a ceiling effect is seen on other effects such as constipation and respiratory depression which is believed to involve interaction with the κ-opioid receptor
See also
14-Methoxydihydromorphinone
References
Kata Kunci Pencarian:
- 14-Methoxymetopon
- 14-Methoxydihydromorphinone
- Equianalgesic
- Low-dose naltrexone
- Black tar heroin
- Codeine/paracetamol
- Protonitazene
- Oxycodone/paracetamol
- Lean (drug)
- Etorphine